Translational Biomarkers in Rectal Cancer

Time

Presentation

09:00–09:10

Welcome and Introduction
iHEALTH / CECAN Collaborative Research Platform

09:10–09:30

Current Clinical Decision-Making in Locally Advanced Rectal Cancer: Where Are the Remaining Gaps?
Pablo Muñoz · Radiation Oncologist, UC / CECAN

09:30–09:50

MRI Assessment of Treatment Response: From Visual Evaluation to Quantitative Imaging Biomarkers
Cecilia Besa · Radiologist, UC / iHEALTH

09:50–10:15

Beyond the pathology report: understanding neoadjuvant treatment response in rectal cancer
Patricia García, PhD · Department of Pathology, UC / CECAN

10:15–10:45

Coffee Break

Time

Presentation

10:45–11:10

Radiomics and Quantitative Imaging: Principles, Challenges and Opportunities for Clinical Translation
Paola Caprile · Medical Physicist, UC / iHEALTH

11:10–11:30

Patient-derived organoids for treatment response assessment in rectal cancer
Diego Muñoz, cPhD · Department of Pathology, UC

11:30–11:50

Multimodal Biomarkers: Integrating Imaging, Omics and Artificial Intelligence for Treatment Response Prediction
Liya Muthukulathil Antony · UC / iHEALTH

11:50–12:30

Quantitative Imaging Biomarkers in Rectal Cancer: From MRI Phenotypes to Radiomics and Spatial Pathology
Joao Miranda, MD Department of Radiology, Mayo Clinic Formerly, Department of Radiology, Memorial Sloan Kettering Cancer Center

12:30–12:45

Closing Remarks and Future Directions of the UC–iHEALTH–CECAN Translational Platform